CLINICAL_TRIALS
trial_result
· 2020-05-08
Clinical Trial Update: A Study to Assess the PK and Safety of PT010 in Subjects With COPD Following Single and Repeat Dose [Phase 1]
Summary
Phase 1 study assessing pharmacokinetics and safety of PT010 in subjects with COPD; trial completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pearl Therapeutics, Inc. | Conditions: Chronic Obstructive Pulmonary Disease | Phase 1 | Status: COMPLETED | Results posted: 2020-05-08